KRAS and colorectal carcinoma: The capacity revealed by KRAS-silenced CRC cells to induce fibroblast migration and activation as well as the secretion of the pro-invasive factor HGF and the immunosuppressive and epithelial-to-mesenchymal inducer TGFβ1 is noteworthy.